Items where Author is "Hitman, G. A."
![[up]](/style/images/multi_up.png)
Up a level
Catchpole, J. 
ORCID: 0000-0001-7901-1797, Padfield, J. ORCID: 0000-0003-2885-2697, Kellermann, V. ORCID: 0009-0004-5969-3769 , Salisbury, C. ORCID: 0000-0002-0602-8050, Das-Munshi, J., Gillard, S. ORCID: 0000-0002-9686-2232, Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Hitman, G. A., Holt, R. I. G., Leber, W., Mark, N., Newman, S. P. ORCID: 0000-0001-6712-6079, Ou, Y., Robinson, C., Röhricht, F., Walker, L., Bird, V., Singer, J. ORCID: 0000-0003-0590-7165 & Hatherall, B. ORCID: 0000-0001-8114-9648 (2026).
A peer-group programme for people with severe mental illness to reduce risk of cardiometabolic disease (PEGASUS): protocol for a feasibility study.
Pilot and Feasibility Studies,
doi: 10.1186/s40814-026-01899-3
Amaefule, C. E., Drymoussi, Z., Dodds, J. , Sweeney, L., Pizzo, E., Daru, J., Robson, J., Poston, L., Khalil, A., Myers, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G. A., Khan, K., Zamora, J., Huda, M. S. B. & Thangaratinam, S. (2018).
Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes (EMmY): a protocol for a randomised, placebo-controlled, double-blind pilot trial..
BMJ Open, 8(9),
article number e022831.
doi: 10.1136/bmjopen-2018-022831
Sivaprasad, S., Vasconcelos, J. C., Prevost, A. T. , Holmes, H., Hykin, P., George, S., Murphy, C., Kelly, J., Arden, G. B., Ahfat, F., Bhatnagar, A., Narendran, N., Chavan, R., Cole, A., Crosby-Nwaobi, R., Patrao, N., Menon, D., Hogg, C., Rubin, G., Leitch-Devlin, L., Egan, C., Shah, N., Mansour, T., Peto, T., Eleftheriadis, H., Gibson, J., Ghulakhszian, A., Vafidis, G., Hughes, E., Jafree, A., Menon, G., Prakash, P., Sandinha, M., Smith, R., Scanlon, P., Chave, S., Aldington, S., Dale, A., Hood, G., Hitman, G. A., Crabb, D. P. ORCID: 0000-0001-8754-3902, Denniston, A., Lewin, D., Grierson, I., Walker, S., Sturt, J. & Sahu, D. (2018).
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.
The Lancet Diabetes and Endocrinology, 6(5),
pp. 382-391.
doi: 10.1016/s2213-8587(18)30036-6